Roy A - Search Results

1

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma.

Atkinson V, Khattak A, Haydon A, Eastgate M, Roy A, Prithviraj P, Mueller C, Brignone C, Triebel F. Atkinson V, et al. Among authors: roy a. J Immunother Cancer. 2020 Nov;8(2):e001681. doi: 10.1136/jitc-2020-001681. J Immunother Cancer. 2020. PMID: 33219094 Free PMC article. Clinical Trial.

2

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.

Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Lao CD, De Menezes JJ, Dalle S, Arance A, Grob JJ, Srivastava S, Abaskharoun M, Hamilton M, Keidel S, Simonsen KL, Sobiesk AM, Li B, Hodi FS, Long GV; RELATIVITY-047 Investigators. Tawbi HA, et al. N Engl J Med. 2022 Jan 6;386(1):24-34. doi: 10.1056/NEJMoa2109970. N Engl J Med. 2022. PMID: 34986285 Free PMC article. Clinical Trial.

3

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

Price TJ, Beeke C, Ullah S, Padbury R, Maddern G, Roder D, Townsend AR, Moore J, Roy A, Tomita Y, Karapetis C. Price TJ, et al. Among authors: roy a. Cancer. 2015 Mar 15;121(6):830-5. doi: 10.1002/cncr.29129. Epub 2014 Nov 6. Cancer. 2015. PMID: 25377235 Free article.

4

Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.

Symonds EL, Pedersen SK, Murray D, Byrne SE, Roy A, Karapetis C, Hollington P, Rabbitt P, Jones FS, LaPointe L, Segelov E, Young GP. Symonds EL, et al. Among authors: roy a. Cancer. 2020 Apr 1;126(7):1460-1469. doi: 10.1002/cncr.32695. Epub 2020 Jan 7. Cancer. 2020. PMID: 31909823 Free PMC article.

5

Rechallenge with Anti-EGFR Therapy in Metastatic Colorectal Cancer (mCRC): Results from South Australia mCRC Registry.

Chong LC, Hardingham JE, Townsend AR, Piantadosi C, Rico GT, Karapetis C, Padbury R, Maddern G, Roy A, Price TJ. Chong LC, et al. Among authors: roy a. Target Oncol. 2020 Dec;15(6):751-757. doi: 10.1007/s11523-020-00760-8. Target Oncol. 2020. PMID: 33068283

6

Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study).

Vatandoust S, Bright T, Roy AC, Abbas MN, Watson DI, Gan S, Bull J, Sorich M, Scott-Hoy A, Luu LJ, Karapetis CS. Vatandoust S, et al. Among authors: roy ac. Asia Pac J Clin Oncol. 2022 Aug;18(4):404-409. doi: 10.1111/ajco.13659. Epub 2021 Nov 23. Asia Pac J Clin Oncol. 2022. PMID: 34811896 Clinical Trial.

7

Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.

Patel D, Townsend AR, Karapetis C, Beeke C, Padbury R, Roy A, Maddern G, Roder D, Price TJ. Patel D, et al. Among authors: roy a. Ann Surg Oncol. 2016 Oct;23(11):3616-3622. doi: 10.1245/s10434-016-5290-4. Epub 2016 Jun 1. Ann Surg Oncol. 2016. PMID: 27251133

8

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol.

Vatandoust S, Bright T, Roy AC, Watson D, Gan S, Bull J, Abbas MN, Karapetis CS. Vatandoust S, et al. BMJ Open. 2019 May 5;9(5):e026732. doi: 10.1136/bmjopen-2018-026732. BMJ Open. 2019. PMID: 31061042 Free PMC article.

9

Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer.

Abbas MN, Klevansky M, Koczwara B, Roy AC, Sukumaran S, Vatandoust S, Karapetis CS. Abbas MN, et al. Cancer Rep (Hoboken). 2022 Mar;5(3):e1487. doi: 10.1002/cnr2.1487. Epub 2021 Jun 30. Cancer Rep (Hoboken). 2022. PMID: 34196124 Free PMC article.

10

Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.

Pedersen SK, Symonds EL, Roy AC, Cornthwaite KJ, LaPointe LC, Young GP. Pedersen SK, et al. Cancer Med. 2023 Jan;12(2):1319-1329. doi: 10.1002/cam4.5008. Epub 2022 Jul 13. Cancer Med. 2023. PMID: 35822405 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,741 results

Search Page